247 related articles for article (PubMed ID: 19138331)
1. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
[TBL] [Abstract][Full Text] [Related]
2. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
[TBL] [Abstract][Full Text] [Related]
3. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
[TBL] [Abstract][Full Text] [Related]
4. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
[TBL] [Abstract][Full Text] [Related]
5. Axonal damage markers in cerebrospinal fluid are increased in ALS.
Brettschneider J; Petzold A; Süssmuth SD; Ludolph AC; Tumani H
Neurology; 2006 Mar; 66(6):852-6. PubMed ID: 16567701
[TBL] [Abstract][Full Text] [Related]
6. Significance of CSF NfL and tau in ALS.
Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
[TBL] [Abstract][Full Text] [Related]
7. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
[TBL] [Abstract][Full Text] [Related]
8. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.
Gonçalves M; Tillack L; de Carvalho M; Pinto S; Conradt HS; Costa J
Clin Chim Acta; 2015 Jan; 438():342-9. PubMed ID: 25261856
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.
Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL
J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis.
Terzi M; Birinci A; Cetinkaya E; Onar MK
Acta Neurol Scand; 2007 May; 115(5):325-30. PubMed ID: 17489943
[TBL] [Abstract][Full Text] [Related]
11. Elevated cerebrospinal fluid and plasma homocysteine levels in ALS.
Valentino F; Bivona G; Butera D; Paladino P; Fazzari M; Piccoli T; Ciaccio M; La Bella V
Eur J Neurol; 2010 Jan; 17(1):84-9. PubMed ID: 19659753
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis.
Tortelli R; Copetti M; Ruggieri M; Cortese R; Capozzo R; Leo A; D'Errico E; Mastrapasqua M; Zoccolella S; Pellegrini F; Simone IL; Logroscino G
Eur J Neurol; 2015 Jan; 22(1):215-8. PubMed ID: 24750431
[TBL] [Abstract][Full Text] [Related]
13. Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum.
Süssmuth SD; Tumani H; Ecker D; Ludolph AC
Neurosci Lett; 2003 Dec; 353(1):57-60. PubMed ID: 14642437
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
[TBL] [Abstract][Full Text] [Related]
15. Is cerebrospinal fluid obtained for diagnostic purpose a good material for biomarker studies in amyotrophic lateral sclerosis?
Chełstowska B; Kuźma-Kozakiewicz M
Biomarkers; 2014 Nov; 19(7):571-7. PubMed ID: 25133306
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
Brettschneider J; Widl K; Ehrenreich H; Riepe M; Tumani H
Neurosci Lett; 2006 Sep; 404(3):347-51. PubMed ID: 16815630
[TBL] [Abstract][Full Text] [Related]
17. Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis.
Lanznaster D; Hergesheimer RC; Bakkouche SE; Beltran S; Vourc'h P; Andres CR; Dufour-Rainfray D; Corcia P; Blasco H
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326346
[TBL] [Abstract][Full Text] [Related]
18. Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis.
Iłecka J
J Neural Transm (Vienna); 2004 Feb; 111(2):167-72. PubMed ID: 14767719
[TBL] [Abstract][Full Text] [Related]
19. Increased cerebrospinal fluid tau protein in multiple sclerosis.
Kapaki E; Paraskevas GP; Michalopoulou M; Kilidireas K
Eur Neurol; 2000; 43(4):228-32. PubMed ID: 10828654
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
Iłzecka J
Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
